Table 1 Characteristics of clients on protease inhibitor-based ART regimens who underwent intensive adherence counseling at an urban public HIV care center in Uganda
Characteristic | Frequency | Proportion (%) |
|---|---|---|
Age (median, IQR), n = 189 | 35, (17–43) |  |
Sex,n = 189 |  |  |
Male | 71 | 38 |
Female | 118 | 62 |
Marital status,n = 189 |  |  |
Married | 65 | 34 |
Not married | 124 | 66 |
Residence,n = 189 |  |  |
Urban | 135 | 71 |
Rural | 54 | 29 |
Initial ART regimen,n = 189 |  |  |
Efavirenz-based | 80 | 42 |
Nevirapine-based | 75 | 40 |
Protease Inhibitor-based | 34 | 18 |
Years on ART (median, IQR),n = 189 | 9 (6–11) |  |
Current ART regimen | Â | Â |
Atazanavir/Ritonavir-based | 114 | 60 |
Lopinavir/Ritonavir-based | 75 | 40 |
Years on PI-based ART (median, IQR),n = 189 | 5 (5–6) |  |
Number of IAC sessions (median, IQR),n = 189 | 3 (3–4) |  |
Duration on IAC in months (median, IQR), n = 189 | 3 (2–4) |  |
Days to viral load test after IAC (median, IQR),n = 189 | 35 (4-121) |  |
Suppression status after IAC (95% CI),n = 186 |  |  |
Yes (Suppressed) | 95 (44–58) | 51 |